Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ABT: Abbott Laboratories -- Ignore unavailable to you. Want to Upgrade?

To: HerbVic who wrote (3)	10/23/2001 12:24:22 AM
From: Paul Senior	Read Replies (1) \| Respond to of 33

Continuing to take profits in my long-term holding of ABT. Stock is at an all-time high and trading at 23x next year's earnings. It has a 12.7% five-year est. earnings growth rate (per Bus. Week, Oct 15, '01). If this all true, I call ABT fully-priced. Most analysts rate this stock a buy. The $800+ million dollar fine ABT and partner had to pay, didn't faze the stock price even a little bit. (Unlike the previous fines/penalties that ABT was subject to last time or two which dropped the stock price.) So, imo, there indeed may be a breakout to new highs now. I prefer to take profits now and reduce my exposure. jmo. And I've been wrong many,many times. Paul Senior